• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home Wellness

Wellness Check: Exercise

byNicholas Ng Fat HingandAvneesh Bhangu
September 22, 2022
in Wellness
Reading Time: 5 mins read
Exercise collage: a smiling older woman with silver hair beside a pair of hand weights, a jump rope and a folded towel
Share on FacebookShare on TwitterShare on LinkedIn

Aerobic and strengthening physical activity may have a dose-response association with mortality

1. In this study, compared to no aerobic physical activity (PA), substantial mortality risk reduction was associated with 1 hour/week of aerobic PA and levelled off at 3 hours/week.
2. Muscle strengthening exercise (MSE) conferred additional mortality risk reduction at 1 time/week, but was no longer beneficial at 7 times/week.

Evidence Rating Level: 2 (Good)

Despite its numerous benefits, more than 1 billion adults do not meet the standard World Health Organization recommendations. Although recent analyses have examined the association between physical activity and all-cause mortality risk, minimal evidence exists surrounding minimum effective doses. As a result, the objective of the present prospective cohort study was to identify the dose-response association and minimum effective doses of aerobic PA and MSE required to result in a clinically significant lower all-cause mortality risk.

The present study used National Health Interview Survey data (1997-2014) and included 416 420 adults from the United States (US). Participants were excluded if they were not permanent residents of the United States, were in correctional facilities, active duty military, or in long-term care facilities. Activity levels were reported using a standardized questionnaire. The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Cox proportional-hazard models were used to evaluate the association between physical activity and all-cause mortality.

Results demonstrated that compared to no aerobic PA, substantial mortality risk reduction was associated with 1 hour/week of aerobic PA and levelled off at 3 hours/week. Muscle strengthening exercise (MSE) conferred additional mortality risk reduction at 1 time/week but was no longer beneficial at 7 times/week. Despite these results, the study was limited by the self-reported nature of physical activity. Nevertheless, this longitudinal analysis of data from a large sample of US adults allowed for a greater understanding of the relationship between PA/MSE and mortality, and may inform US healthcare providers.

RELATED REPORTS

Spousal traumatic brain injury is associated with increased mortality in the uninjured partner

2 Minute Medicine Rewind November 9, 2026

 

Regular physical activity may confer protection against adverse COVID-19 outcomes

1. In this study, engaging in regular physical activity had a lower risk of infection, hospitalization, severe COVID-19 illness, and COVID-19 related death compared to inactive peers.

2. The greatest benefit was achieved at 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week.

Evidence Rating Level: 1 (Excellent)

Physical activity is known to have a multitude of beneficial health effects as well as enhancing immunity. To date, the link between regular physical activity and COVID-19 outcomes has been poorly understood. As a result, the aim of the present systematic review and meta-analysis was to quantify the association between physical activity and the risk of COVID-19 infection, hospitalization, severe illness and death in adults.

Of 4063 identified records, 16 studies were included in the systematic review (n=1 853 610) from database inception to March 2022. Studies were eligible if they studied the effects of physical activity (questionnaires or objective measures) on COVID-19 outcomes. Studies were excluded If participants self-reported COVID-19 infection or were hospitalized. Quality of the evidence was evaluated using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) was used to evaluate. Statistical analysis was performed using a random-effects inverse-variance model.

Results demonstrated that engaging in regular physical activity had a lower risk of infection, hospitalization, severe COVID-19 illness, and COVID-19 related death compared to inactive peers. Furthermore, the greatest benefit was achieved at 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity physical activity per week. Despite these findings, the study was limited by the potential for the pooled estimates to be confounded. Nonetheless, these results may help guide physicians in encouraging physical activity among patients to reduce the burden of COVID-19 health outcomes.

 

Occupational and leisure physical activity may have varying effects on inflammation 

1. Lower leisure time physical activity and higher occupational physical activity were associated with increased high-sensitivity C reactive protein (hs-CRP) levels.
2. When analyzed as continuous variables, only leisure time physical activity was strongly associated with hs-CRP levels.

Evidence Rating Level: 2 (Good)

Paradoxically, physical activity associated with one’s occupation has been shown in the literature to increase cardiovascular disease and mortality; a finding that does not hold true for physical activity associated with leisure. Though many mechanisms have been proposed, sustained systemic inflammation (measured through hs-CRP levels) may be an important contributor. In order to further study this association, the objective of the present cross-sectional study was to determine the extent to which physical activity performed during work and leisure time was associated with systemic inflammation.

The present study used data from the Copenhagen Aging and Midlife Biobank (CAMB) cohort. Of 12656 invited participants, 5304 had blood samples taken, including the hs-CRP biomarker. Occupational physical activity was measured based on self-reported job history with a job exposure matrix. Leisure time physical activity was self-reported using the CAMB questionnaire. The association between the two types of physical activity and hs-CRP was done using multivariable linear regression models as well as post-hoc analyses.

Results demonstrated that lower leisure time physical activity and higher occupational physical activity were associated with increased high-sensitivity C reactive protein (hs-CRP) levels. Furthermore, when analyzed as continuous variables, only leisure time physical activity was strongly associated with hs-CRP levels. Despite these findings, the study was limited by the risk of misclassification, as physical activity was based on job title. Nonetheless, the inclusion of a large number of participants strengthened the findings of the present study and the fact that systemic inflammation may in fact explain the physical activity paradox.

 

Lower limb osteoarthritis may be more prevalent in retired Olympians

1. In this study, one in four retired Olympians reported physician-diagnosed osteoarthritis (OA), with injury being associated with an increased risk of OA and pain at the knee, hip, and ankle.
2. After adjusting for risk factors, Olympians were more likely to have knee and hip OA after injury compared to the general population.

Evidence Rating Level: 3 (Average)

Joint injury may be a risk factor for future development of OA, especially for elite sport participants. To date, few studies have compared the magnitude of OA in different body sites in elite athletes (such as Olympians) and the general population. As a result, the objective of the present cross-sectional study was to compare the prevalence of lower limb physician-diagnosed OA and pain in retired Olympians, as well as determine contributing factors.

The present study included self-reported data from an online survey administered to Olympians (through Olympic association platforms) and the general population (in three different phases). 3357 retired Olympians (median age= 44.7 years) and 1735 (median age= 40.5 years) individuals from the general population completed the survey between April 2018 and June 2019. Retired Olympians had to be 16 years or older and competed in at least one summer/and or winter Olympic game. General population controls included those older than 16 years who did not compete in the Olympics. For statistical analyses, independent t-tests, Mann-Whitney U tests, Chi-square testing and logistic regression were used.

Results demonstrated that one in four retired Olympians reported physician-diagnosed osteoarthritis (OA), and injury was associated with an increased risk of OA and pain at the knee, hip and ankle. Furthermore, after adjusting for risk factors, Olympians were more likely to have knee and hip OA after injury, compared to the general population. Despite these results, the study was limited by only representing 4% of the total retired Olympian population. Nonetheless, the present results may help inform prevention strategies to reduce the risk of lower limb OA in Olympians after retirement from their sport.

FDA approvedFor COVID-19: Xocova (ensitrelvir), May 29, 2026→

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: aerobicarthritisCOVID-19exerciseinflammationmortalityOAolympianolympicswellness
Previous Post

Prenatal cannabis exposure associated with psychopathology in childhood and adolescence

Next Post

Nonpharmaceutical interventions increase sleep duration in children

RelatedReports

Collage on head injury in adults: a calm man beside an engraved brain drawing, a bicycle helmet and a small penlight
Chronic Disease

Spousal traumatic brain injury is associated with increased mortality in the uninjured partner

November 13, 2026
A profile of a human head with a visible brain, surrounded by descending bar graphs and doors leading into a fading background, suggesting themes of dementia and cognitive decline.
Weekly Rewinds

2 Minute Medicine Rewind November 9, 2026

November 11, 2026
A balance scale weighing an antiviral medication against a hospital entrance and a patient, symbolizing the outcomes of COVID-19 treatment.
2MM Trial Briefs

101-PGC-005 improved hospitalized patients with COVID-19 faster than systemic dexamethasone in topline phase 2/3 results

November 10, 2026
A pregnant woman consults with a healthcare provider, who is holding a clipboard and discussing maternal health topics. A weight scale and imagery of a fetus are also present.
Cardiology

Medicaid status, race and ethnicity are independently associated with increased odds of severe maternal morbidity

November 6, 2026
Next Post
Children's sleep collage: a young girl asleep under a patchwork quilt beside a plush rabbit, with a paper moon and stars

Nonpharmaceutical interventions increase sleep duration in children

ABCD2 Score: Predicting Early Stroke Risk After Transient Ischemic Attack (TIA) [Classics Series]

PECARN Prediction rules for children at a low risk of clinically-important traumatic brain injury [Classics Series]

Glaucoma collage: a close-up of one eye, a side-view drawing of the eyeball and optic nerve, and a blank eye drop bottle

Selective laser trabeculectomy offers long-term benefits over eye drops for glaucoma

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
  • Spousal traumatic brain injury is associated with increased mortality in the uninjured partner
  • Use of β3 adrenergic agonists and anticholinergics for overactive bladder are associated with similar dementia risk
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.